Cargando…
Entecavir-Associated Thrombocytopenia: A Case Report and Review of the Pathophysiology, Diagnosis, and Treatment of a Rare but Reversible Cause of Thrombocytopenia
Drug-associated thrombocytopenia is often unrecognized. We report a 76-year-old female with lymphoma who presented with easy bruising and oral bleeding. She had undergone screening for hepatitis B virus (HBV) prior to starting rituximab and was found to have hepatitis B core serum antibody (IgG anti...
Autores principales: | Yohannan, Binoy, Luu, Dai Chu N., Feldman, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434310/ https://www.ncbi.nlm.nih.gov/pubmed/30993023 http://dx.doi.org/10.1155/2019/4319148 |
Ejemplares similares
-
Entecavir-associated thrombocytopenia
por: Yu, Yi, et al.
Publicado: (2021) -
Cyclic Thrombocytopenia: A Rare Cause of Recurrent Thrombocytopenia
por: Oyenuga, Mosunmoluwa, et al.
Publicado: (2022) -
The pathophysiology of thrombocytopenia in chronic liver disease
por: Mitchell, Oscar, et al.
Publicado: (2016) -
Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia
por: Vayne, Caroline, et al.
Publicado: (2020) -
Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management
por: Patriarcheas, Vasileios, et al.
Publicado: (2020)